IL6 and colonic neoplasm: In a mouse experiment using the mouse colon cancer cell line CT-26, IL-6 deletion in mice enhances antitumor immunity by augmenting type-1 immunity, suggesting the immunosuppressive role of IL-6 in the tumor microenvironment [78].